INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17427, 'Dexaphen syrup 120ml', 'ديكسافين شراب 120 مل', '24', '15', 'Antihistamine.antiallergy.combined with glucocorticoid steroid', 'Chlorpheniramine+dexamethasone', 'Pharco', 'Syrup', 'شراب', '120ml', '1', '', 'dexamethasone description an anti-inflammatory 9-fluoro-glucocorticoid. mechanism of action dexamethasone is a glucocorticoid agonist. unbound dexamethasone crosses cell membranes and binds with high affinity to specific cytoplasmic glucocorticoid recepto', '6223000012604', '', 3628, '2024-07-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17428, 'Dexaprof 25mg 20 f.c. tabs.', 'ديكسابروف 25 مجم 20 قرص', '16', '', 'Nsaid.propionic acid derivatives', 'Dexketoprofen', 'Novartis', 'Tab', 'أقراص', '25mg', '2', '', 'about dexketoprofen nonsteroidal anti-inflammatory drugs analgesic propionic acid derivative. mechanism of action of dexketoprofen dexketoprofen works by blocking the action of a substance in the body called cyclo-oxygenase (cox). cyclo-oxygenase is invol', '', '', 1007, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AE17', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17429, 'Dexaron plus eye/ear drops 5 ml', 'ديكسارون بلس نقط للعين والأذن 5 مل', '9', '', '', 'Dexamethasone+neomycin sulphate+polymyxin b sulphate', 'Amoun', 'Drops', 'نقط', '5 ml', '1', '', 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhib', '6221025008268', '', 953, '2022-07-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'A07AA05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17430, 'Dexaron plus eye/ear oint.', 'ديكسارون بلس مرهم العين / الأذن', '7', '', '', 'Dexamethasone+neomycin sulphate+polymyxin b sulphate', 'Amoun', 'Oint', 'مرهم', '', '1', '', 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhib', '6221025008251', '', 847, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'A07AA05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17431, 'Dexatob eye drops 5 ml', 'ديكساتوب قطرة عين 5 مل', '37', '26', 'Antibiotic with glucocorticoid', 'Dexamethasone+tobramycin', 'Sigma tec > october pharma', 'Drops', 'نقط', '5 ml', '1', '', 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. mechanism of action of dexamethasone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and ca', '', '', 1313, '2025-08-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17433, 'Step happy 50 gm massage gel', 'ستيب هابي مساج جل 50 جم', '40', '', 'Massage gel', 'Carbomer + triethylamine + propylene glycol + menthol + eucalyptus + camphor oil + thyme oil + clove oil + peppermint oil + panthenol + tocopherol acetate + sodium methylparaben', 'Sehha pharma', 'Gel', 'جل', '50 gm', '1', '', '', '', '', 1123, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17434, 'Dexatopic topical cream 20 gm', 'ديكساتوبيك كريم موضعي 20 جم', '12', '', '', 'Chlorhexidine+dexamethasone+nandrolone', 'Sedico > schering plough', 'Cream', 'كريم', '20 gm', '1', '', 'about chlorhexidine a bisbiguanide antimicrobial agent anti-infective antiseptic. mechanism of action of chlorhexidine this drug has positive charge so it attach to the negative charge cell wall. this destabilizes and destroys the integrity and penetrates', '6221042305012', '', 791, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17435, 'Doliprane 1gm 8 sachets', 'دوليبران 1جم 8 اكياس', '36', '30', 'Analgesic.antipyrteic', 'Paracetamol(acetaminophen)', 'Sanofi', 'Sachet', 'أكياس', '1gm', '1', 'مسكن -- خافض للحرارة -- امن علي الحوامل والمرضعات -- مسكن للصداع -- مسكن لالام الاسنان -- مسكن لاعراض البرد -- لالام العظام -- امن على المعدة -- امن للاطفال -- امن لمرضى الضغط والسكر', '', '3400936246980', '', 1319, '2023-10-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N02AJ01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17436, 'Dexatrol eye/ear drops 5 ml', 'ديكساترول قطرة للعين والاذن 5 مل', '27', '19', '', 'Dexamethasone+neomycin sulphate+polymyxin b sulphate', 'Eipico', 'Drops', 'نقط', '5 ml', '1', 'مضاد حيوي', 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. about neomycin an aminoglycoside antibiotic ammonium detoxicant. mechanism of action of neomycin this aminoglycoside cause protein synthesis inhib', '6221032233103', '', 13222, '2024-07-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'A07AA05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17437, 'Dexawest 30 mg 14 caps', 'ديكساويست 30مجم 14 كبسولة', '66', '44', 'Peptic ulcer.proton pump inhibitor', 'Dexlansoprazole', 'Western pharmaceuticals industries', 'Cap', 'كبسولة', '30 mg', '2', 'علاج قرحة المعدة مثبط لمخض البروتونات علاج اعراض ارتجاع المريء وعلاج الهيلكوباكتر بيلوري', '', '', '', 4803, '2025-02-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of [DB00448], which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes [DB00213], [DB00338], and [DB00448]) [A178084], dexlansoprazole MR has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood; 25% of the dose is released at pH 5.5 in the proximal duodenum, while the remaining 75% is released at pH 6.75 in the distal small intestine [A19567]. As a result, dexlansoprazole has a peak concentration within 1-2 hours after dosing and another within 4-5 hours [FDA Label]. Dexlansoprazole''s unique pharmacokinetics addresses limitations of the older generation PPIs including short plasma half-life, break-through symptoms, and need for meal-associated dosing [A19568]. These characteristics make dexlansoprazole a good option for people who struggle with adherence and strict dosage timing before meals[A178087, A19566]. 

Dexlansoprazole exerts its stomach acid-suppressing effects in the same way as other drugs in the PPI family by inhibiting the final step in gastric acid production. Dexlansoprazole targets the (H+, K+)-ATPase enzyme, which is involved in the secretion of hydrochloric acid through the exchange of H+ ions from the cytoplasm for K+ ions. Normally functioning (H+, K+)-ATPase stimulates hydrochloric acid secretion into the gastric lumen thereby increasing stomach acidity and lowering pH. Once absorbed into circulation, dexlansoprazole covalently binds to the sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells, which leads to inhibition of both basal and stimulated gastric acid secretion. Despite dexlansoprazole''s unique pharmacokinetic profile, efficacy in management of GERD symptoms is considered similar to other medications within the PPI class including [DB00338], [DB00736], [DB00448], [DB00213], and [DB01129].

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as dexlansoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life [A177571]. PPIs such as dexlansoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 

Dexlansoprazole doses should be slowly lowered, or tapered, before discontinuing as rapid discontinuation of PPIs such as dexlansoprazole may cause a rebound effect and a short term increase in hypersecretion [A177574].', '["A02BC06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17439, 'Dexiclave 1 gm 10 f.c. tabs', 'ديكسيكلاف 1 جم 5 اقراص', '39', '', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > novell pharma', 'Tab', 'أقراص', '1 gm', '1', '', '', '', '', 1527, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17440, 'Aaa', 'ششش', '118', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 747, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17441, 'Dexiclave 312.5mg/5ml susp. 60 ml', 'ديكسيكلاف 312.5 مجم / 5 مل معلق 60 مل', '19', '', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > novell pharma', 'Susp', 'معلق', '312.5mg', '1', '', 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '', '', 896, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17442, 'Aaa', 'ششش', '112', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 694, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17443, 'Dexiclave 375 mg 10 f.c. tabs.', 'ديكسيكلاف 375 مجم 10 اقراص', '22', '', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > novell pharma', 'Tab', 'أقراص', '375 mg', '1', '', 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '', '', 948, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17444, 'Aaa', 'ششش', '121', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 741, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17445, 'Dexiclave 457mg/5ml susp. 60 ml', 'ديكسيكلاف 457 مجم / 5 مل معلق 60 مل', '28', '', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > novell pharma', 'Susp', 'معلق', '457mg', '1', '', 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '', '', 840, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17447, 'Dexiclave 625 mg 12 f.c. tabs.', 'ديكسكلاف 625 مجم 12 اقراص', '38', '', 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+clavulanic acid', 'Rameda > novell pharma', 'Tab', 'أقراص', '625 mg', '3', 'بنسلين بشري -- مضاد حيوي', 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '', '', 1246, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17448, 'Dexilant 30 mg 14 caps.', 'ديكسيلانت 30 مجم 14 كبسولة', '85', '', 'Peptic ulcer.proton pump inhibitor', 'Dexlansoprazole', 'Takeda', 'Cap', 'كبسولة', '30 mg', '2', '', 'dexlansoprazole is a proton pump inhibitor (ppi) that is for the treatment of erosive esophagitis and gastro-oesophageal reflux disease. it is similar in effectiveness to other ppis. dexlansoprazole is used to heal and maintain healing of erosive esophagi', '', '', 1318, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of [DB00448], which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes [DB00213], [DB00338], and [DB00448]) [A178084], dexlansoprazole MR has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood; 25% of the dose is released at pH 5.5 in the proximal duodenum, while the remaining 75% is released at pH 6.75 in the distal small intestine [A19567]. As a result, dexlansoprazole has a peak concentration within 1-2 hours after dosing and another within 4-5 hours [FDA Label]. Dexlansoprazole''s unique pharmacokinetics addresses limitations of the older generation PPIs including short plasma half-life, break-through symptoms, and need for meal-associated dosing [A19568]. These characteristics make dexlansoprazole a good option for people who struggle with adherence and strict dosage timing before meals[A178087, A19566]. 

Dexlansoprazole exerts its stomach acid-suppressing effects in the same way as other drugs in the PPI family by inhibiting the final step in gastric acid production. Dexlansoprazole targets the (H+, K+)-ATPase enzyme, which is involved in the secretion of hydrochloric acid through the exchange of H+ ions from the cytoplasm for K+ ions. Normally functioning (H+, K+)-ATPase stimulates hydrochloric acid secretion into the gastric lumen thereby increasing stomach acidity and lowering pH. Once absorbed into circulation, dexlansoprazole covalently binds to the sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells, which leads to inhibition of both basal and stimulated gastric acid secretion. Despite dexlansoprazole''s unique pharmacokinetic profile, efficacy in management of GERD symptoms is considered similar to other medications within the PPI class including [DB00338], [DB00736], [DB00448], [DB00213], and [DB01129].

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as dexlansoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life [A177571]. PPIs such as dexlansoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 

Dexlansoprazole doses should be slowly lowered, or tapered, before discontinuing as rapid discontinuation of PPIs such as dexlansoprazole may cause a rebound effect and a short term increase in hypersecretion [A177574].', '["A02BC06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17449, 'Dexilant 60 mg 14 caps', 'ديكسيلانت 60مجم 14 كبسولة', '154', '', 'Peptic ulcer.proton pump inhibitor', 'Dexlansoprazole', 'Takeda', 'Cap', 'كبسولة', '60 mg', '2', 'علاج قرحة المعدة والأثنى عشر', '', '7038319105744', '', 3057, '2022-06-02', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of [DB00448], which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes [DB00213], [DB00338], and [DB00448]) [A178084], dexlansoprazole MR has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood; 25% of the dose is released at pH 5.5 in the proximal duodenum, while the remaining 75% is released at pH 6.75 in the distal small intestine [A19567]. As a result, dexlansoprazole has a peak concentration within 1-2 hours after dosing and another within 4-5 hours [FDA Label]. Dexlansoprazole''s unique pharmacokinetics addresses limitations of the older generation PPIs including short plasma half-life, break-through symptoms, and need for meal-associated dosing [A19568]. These characteristics make dexlansoprazole a good option for people who struggle with adherence and strict dosage timing before meals[A178087, A19566]. 

Dexlansoprazole exerts its stomach acid-suppressing effects in the same way as other drugs in the PPI family by inhibiting the final step in gastric acid production. Dexlansoprazole targets the (H+, K+)-ATPase enzyme, which is involved in the secretion of hydrochloric acid through the exchange of H+ ions from the cytoplasm for K+ ions. Normally functioning (H+, K+)-ATPase stimulates hydrochloric acid secretion into the gastric lumen thereby increasing stomach acidity and lowering pH. Once absorbed into circulation, dexlansoprazole covalently binds to the sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells, which leads to inhibition of both basal and stimulated gastric acid secretion. Despite dexlansoprazole''s unique pharmacokinetic profile, efficacy in management of GERD symptoms is considered similar to other medications within the PPI class including [DB00338], [DB00736], [DB00448], [DB00213], and [DB01129].

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as dexlansoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life [A177571]. PPIs such as dexlansoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 

Dexlansoprazole doses should be slowly lowered, or tapered, before discontinuing as rapid discontinuation of PPIs such as dexlansoprazole may cause a rebound effect and a short term increase in hypersecretion [A177574].', '["A02BC06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17450, 'Kofzym 120 ml syrup', 'كوفزيم شراب 120 مل', '43', '', 'Support respiratory system health', 'Total carbohydrate+sugars+ivy leaf extract+licorice root extract+thyme leaf extract', 'Zyma pharma', 'Syrup', 'شراب', '120 ml', '1', '', '', '', '', 1325, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17451, 'Dexketoprofen 25 mg 20 scored f.c.tab.', 'ديكسكيتوبروفين 25 مجم 20 قرص', '24', '', 'Nsaid.propionic acid derivatives', 'Dexketoprofen', 'Marcyrl co. > bahrain pharma', 'Tab', 'أقراص', '25 mg', '2', '', 'about dexketoprofen nonsteroidal anti-inflammatory drugs analgesic propionic acid derivative. mechanism of action of dexketoprofen dexketoprofen works by blocking the action of a substance in the body called cyclo-oxygenase (cox). cyclo-oxygenase is invol', '6223002571093', '', 926, '2024-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AE17', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17452, 'Dexolant 30 mg 7 caps.', 'ديكسولانت 30مجم 7 كبسولة', '13', '', 'Peptic ulcer.proton pump inhibitor', 'Dexlansoprazole', 'Biopharm egypt', 'Cap', 'كبسولة', '30 mg', '1', '', 'dexlansoprazole is a proton pump inhibitor (ppi) that is for the treatment of erosive esophagitis and gastro-oesophageal reflux disease. it is similar in effectiveness to other ppis. dexlansoprazole is used to heal and maintain healing of erosive esophagi', '', '', 821, '2022-07-07', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of [DB00448], which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes [DB00213], [DB00338], and [DB00448]) [A178084], dexlansoprazole MR has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood; 25% of the dose is released at pH 5.5 in the proximal duodenum, while the remaining 75% is released at pH 6.75 in the distal small intestine [A19567]. As a result, dexlansoprazole has a peak concentration within 1-2 hours after dosing and another within 4-5 hours [FDA Label]. Dexlansoprazole''s unique pharmacokinetics addresses limitations of the older generation PPIs including short plasma half-life, break-through symptoms, and need for meal-associated dosing [A19568]. These characteristics make dexlansoprazole a good option for people who struggle with adherence and strict dosage timing before meals[A178087, A19566]. 

Dexlansoprazole exerts its stomach acid-suppressing effects in the same way as other drugs in the PPI family by inhibiting the final step in gastric acid production. Dexlansoprazole targets the (H+, K+)-ATPase enzyme, which is involved in the secretion of hydrochloric acid through the exchange of H+ ions from the cytoplasm for K+ ions. Normally functioning (H+, K+)-ATPase stimulates hydrochloric acid secretion into the gastric lumen thereby increasing stomach acidity and lowering pH. Once absorbed into circulation, dexlansoprazole covalently binds to the sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells, which leads to inhibition of both basal and stimulated gastric acid secretion. Despite dexlansoprazole''s unique pharmacokinetic profile, efficacy in management of GERD symptoms is considered similar to other medications within the PPI class including [DB00338], [DB00736], [DB00448], [DB00213], and [DB01129].

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as dexlansoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life [A177571]. PPIs such as dexlansoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 

Dexlansoprazole doses should be slowly lowered, or tapered, before discontinuing as rapid discontinuation of PPIs such as dexlansoprazole may cause a rebound effect and a short term increase in hypersecretion [A177574].', '["A02BC06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17453, 'Dexolant 60 mg 7 caps.', 'دكسولانت 60مجم 7 كبسولات', '18', '', 'Peptic ulcer.proton pump inhibitor', 'Dexlansoprazole', 'Biopharm egypt', 'Cap', 'كبسولة', '60 mg', '1', 'يعمل علي قلة الارتجاع والحموضة -- يقلل من التهابات المعدة -- علاج قرحة المعدة', 'dexlansoprazole is a proton pump inhibitor (ppi) that is for the treatment of erosive esophagitis and gastro-oesophageal reflux disease. it is similar in effectiveness to other ppis. dexlansoprazole is used to heal and maintain healing of erosive esophagi', '', '', 1345, '2022-04-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Dexlansoprazole is a new generation proton pump inhibitor (PPI) used for the management of symptoms associated with gastroesophageal reflux disease (GERD) and erosive esophagitis. Dexlansoprazole is the R-enantiomer of [DB00448], which is composed of a racemic mixture of the R- and S-enantiomers. Compared to the older generation of PPIs (which includes [DB00213], [DB00338], and [DB00448]) [A178084], dexlansoprazole MR has a unique pharmacokinetic profile due to its delayed-release and dual-delivery release system. The active ingredient is released in two phases at different pH values and at different time points, resulting in two peak concentrations in the blood; 25% of the dose is released at pH 5.5 in the proximal duodenum, while the remaining 75% is released at pH 6.75 in the distal small intestine [A19567]. As a result, dexlansoprazole has a peak concentration within 1-2 hours after dosing and another within 4-5 hours [FDA Label]. Dexlansoprazole''s unique pharmacokinetics addresses limitations of the older generation PPIs including short plasma half-life, break-through symptoms, and need for meal-associated dosing [A19568]. These characteristics make dexlansoprazole a good option for people who struggle with adherence and strict dosage timing before meals[A178087, A19566]. 

Dexlansoprazole exerts its stomach acid-suppressing effects in the same way as other drugs in the PPI family by inhibiting the final step in gastric acid production. Dexlansoprazole targets the (H+, K+)-ATPase enzyme, which is involved in the secretion of hydrochloric acid through the exchange of H+ ions from the cytoplasm for K+ ions. Normally functioning (H+, K+)-ATPase stimulates hydrochloric acid secretion into the gastric lumen thereby increasing stomach acidity and lowering pH. Once absorbed into circulation, dexlansoprazole covalently binds to the sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells, which leads to inhibition of both basal and stimulated gastric acid secretion. Despite dexlansoprazole''s unique pharmacokinetic profile, efficacy in management of GERD symptoms is considered similar to other medications within the PPI class including [DB00338], [DB00736], [DB00448], [DB00213], and [DB01129].

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as dexlansoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life [A177571]. PPIs such as dexlansoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 

Dexlansoprazole doses should be slowly lowered, or tapered, before discontinuing as rapid discontinuation of PPIs such as dexlansoprazole may cause a rebound effect and a short term increase in hypersecretion [A177574].', '["A02BC06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17454, 'Revital hair lotion 125 ml', 'ريفيتال لوشن للشعر 125 مل', '130', '', 'Hair care', '', 'Mash premiere', 'Lotion', 'لوشن', '125 ml', '1', '', '', '', '', 716, '2023-04-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17455, 'Aaa', 'ششش', '4', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 782, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17456, 'Dexpanol wound 5gm/100ml topical spray', 'ديكسبانول 5 جم / 100 مل بخاخ موضعي', '8', '', 'Healing topical', 'Dexapanthenol', 'Global napi pharmaceuticals > stada', 'Spray', 'بخاخ', '5gm', '1', '', 'dexapanthenol-containing creams have been widely used for treatment of lesions (superficial wounds) of the skin and mucous membranes. dexapanthenol is converted in tissues to pantothenic acid a component of coenzyme a. coenzyme a catalyses early steps in', '', '', 1092, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17457, 'Dexpanthenol 5% topical cream 20 gm', 'ديكسبانثينول 5% كريم 20 جم', '4', '4', 'Moisturizing topicals', 'Dexapanthenol', 'Amriya', 'Cream', 'كريم', '5%', '1', 'علاج التشقق الجلدي', 'dexapanthenol-containing creams have been widely used for treatment of lesions (superficial wounds) of the skin and mucous membranes. dexapanthenol is converted in tissues to pantothenic acid a component of coenzyme a. coenzyme a catalyses early steps in', '6221075220030', '', 15503, '2022-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17458, 'Dextrafast 25mg 20 f.c. tabs.', 'دكسترافاست 25مجم20 قرص', '34', '21', 'Nsaid.propionic acid derivatives', 'Dexketoprofen', 'Mash premiere', 'Tab', 'أقراص', '25mg', '2', '', 'about dexketoprofen nonsteroidal anti-inflammatory drugs analgesic propionic acid derivative. mechanism of action of dexketoprofen dexketoprofen works by blocking the action of a substance in the body called cyclo-oxygenase (cox). cyclo-oxygenase is invol', '6222001400335', '', 2168, '2024-12-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AE17', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17459, 'Dextran (70) 6% w/v in normal saline i.v.inf.', 'ديكستران (70) 6% في نورمال سالين محلول وريد', '18', '', 'Sterile solution', 'Dextran+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '6%', '1', '', '', '', '', 1058, '2022-07-29', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17460, 'Dextran 40 (10 %w/v) intr.infusion & glucose 5 % b.p.', 'ديكستران 40 (10%) والجلوكوز 5% 500 مل', '18', '', 'Sterile solution', 'Dextran', 'Otsuka', 'Unknown', 'غير محدد', '10 %', '1', '', '', '', '', 690, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'None', '[]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17461, 'Rancycal 30tablet', 'رانسيكال 30 قرص', '75', '', 'Multivitamin', 'Calcium-magnesium-zinc-selenium-vit d3-boron-copper-manganese', 'Amazingpharma', 'Tablet', 'أقراص', '', '3', '', '', '', '', 1670, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17462, 'Terasag 60 gm massage gel', 'تيراساج مساج جل 60 جم', '55', '', 'Analgesic', 'Camphor oil+menthol+eucalyptus+peppermint oil+clove oil+thyme extract+apricot oil+vit c+vit e', 'Propharm', 'Gel', 'جل', '60 gm', '1', '', '', '', '', 901, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17463, 'Dextran 70 6% normal saline', 'ديكستران 70 6% نورمال سالين', '18', '', 'Sterile solution', 'Dextran', 'Otsuka', 'Unknown', 'غير محدد', '6%', '1', '', '', '', '', 848, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'None', '[]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17464, 'Dextran 70 6% w/v glucose 5% i.v.infusion b.p 2003', 'ديكستران 70 (6%) & جلوكوز 5%', '20', '', 'Sterile solution', 'Dextran+glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '6%', '1', '', '', '', '', 910, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17465, 'Dextran 70 in normal saline b.p 2003 i.v.infusion', 'ديكستران 70 في نورمال سالين محلول وريد', '4', '', 'Sterile solution', 'Dextran+sodium chloride', 'El nile.', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 685, '2022-07-17', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17466, 'Dextrose 10% & sodium chloride 0.9% (otsuka) i.v. inf. 1000 ml (n/a)', 'دكستروز 10% و صوديوم كلوريد 0.9% اوتوسوكا 1000 مل', '6', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '10%', '1', '', '', '', '', 801, '2022-07-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17467, 'Dextrose 10% & sodium chloride 0.9% (otsuka) i.v. inf. 500 ml (n/a)', 'دكستروز 10% و صوديوم كلورايد 0.9% اوتوسوكا محلول وريدي 500 مل', '4', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '10%', '1', '', '', '', '', 712, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17468, 'Dextrose 10% & sodium chloride 0.9% (otsuka) i.v. inf. 500 ml (rubber cap)', 'دكستروز 10% صوديوم كلوريد 0.9% اوتوسوكا محلول وريدي 500 مل غطاء مطاط', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Cap', 'كبسولة', '10%', '1', '', '', '', '', 778, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17469, 'Dextrose 10% (al kamal) i.v. inf. 500 ml', 'دكستروز 10% الكمال محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Al kamal importing & marketing co', 'Unknown', 'غير محدد', '10%', '1', '', '', '', '', 830, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17470, 'Dextrose 10% (allmed) i.v. inf. 500 ml', 'دكستروز 10% اولميد محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Unknown', 'غير محدد', '10%', '1', '', '', '', '', 720, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17471, 'Dextrose 10% (allmed) i.v. inf. 500 ml (rubber cap)', 'دكستروز 10% اولميد محلول وريدي 500 مل غطاء مطاط', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Cap', 'كبسولة', '10%', '1', '', '', '', '', 922, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17472, 'Dextrose 25% (el nile) i.v. inf. 500 ml', 'دكستروز 10% النيل محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'El nile.', 'Unknown', 'غير محدد', '25%', '1', '', '', '', '', 787, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17473, 'Dextrose 25% (el nile) i.v. inf. 500 ml (rubber cap)', 'دكستروز 10% النيل محلول وريدي 500 مل غطاء مطاطي', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'El nile.', 'Cap', 'كبسولة', '25%', '1', '', '', '', '', 807, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17474, 'Dextrose 25% (allmed) i.v. inf. 500 ml', 'دكستروز 25% اولميد محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Unknown', 'غير محدد', '25%', '1', '', '', '', '', 729, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17475, 'Dextrose 25% (allmed) i.v. inf. 500 ml (rubber cap)', 'دكستروز 25% اولميد محلول وريدي 500 مل بغطاء مطاطي', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Cap', 'كبسولة', '25%', '1', '', '', '', '', 791, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17476, 'Dextrose 25% (25ml) i.v.infusion', 'دكستروز 25% 25 مل محلول وريد', '5', '', 'Parenteral solutions', 'Glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '25%', '1', '', '', '', '', 843, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17477, 'Dextrose 25% (500ml) (rubber cap) i.v.infusion', 'دكستروز 25% 500مل غطاء مطاط محلول وريد', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Cap', 'كبسولة', '25%', '1', '', '', '', '', 824, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17478, 'Happy care mouth wash 125 ml', 'هابي كير غسول للفم 125 مل', '40', '', 'Oral care', '', 'Elarabi medical', 'Mouth wash', 'غسول للفم', '125 ml', '1', '', '', '', '', 673, '2022-09-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17479, 'Dextrose 25% (otsuka) i.v. inf. 25 ml', 'دكستروز 25% اوتوسوكا محلول وريدي زجاجة 25 مل', '5', '', 'Sterile solution', 'Glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '25%', '1', '', '', '', '', 979, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17480, 'Dextrose 25% (otsuka) i.v. inf. 500 ml (rubber cap)', 'دكستروز 25% اوتوسوكا محلول وريدي زجاجة 500 مل بغطاء مطاطي', '20', '', 'Sterile solution', 'Glucose (dextrose)', 'Otsuka', 'Cap', 'كبسولة', '25%', '1', '', '', '', '', 704, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17482, 'Dextrose 3.3% & sodium chloride 0.3% (otsuka) i.v. inf. 250 ml', 'دكستروز 3.3% وصوديوم كلورايد 0.3% اوتوسوكا محلول وريدي 250 مل', '7', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '3.3%', '1', '', '', '', '', 726, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17483, 'Dextrose 3.3% & sodium chloride 0.3% (otsuka) i.v. inf. 500 ml', 'دكستروز 3.3% وصوديوم كلورايد 0.3% اوتوسوكا محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '3.3%', '1', '', '', '', '', 661, '2022-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17484, 'Dextrose 40% (otsuka) i.v. inf. 500 ml', 'دكستروز 40% (اوتسوكا) محلول وريدي زجاجة 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '40%', '1', '', '', '', '', 705, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17485, 'Dextrose 5% & ringer (otsuka) i.v. inf. 1000 ml', 'دكستروز 5% ورينجر اوتوسوكا محلول وريدي 1000 مل', '13', '', 'Sterile solution', 'Calcium chloride+glucose (dextrose)+potassium chloride+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 990, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17486, 'Dextrose 5% & ringer (otsuka) i.v. inf. 500 ml', 'دكستروز 5% ورينجر اوتوسوكا محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Calcium chloride+glucose (dextrose)+potassium chloride+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 870, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17487, 'Dextrose in 5% & 0.9 % sodium cloride (500ml) (rom) i.v.infusion', 'دكستروز 5%و 0.9%صوديوم كولوريد 500مل محلول', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Allmed middle east', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 1086, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17488, 'Dextrose 50% (otsuka) i.v. inf. 500 ml', 'دكستروز 50% اوتوسوكا محلول وريدي 500 مل', '14', '', 'Sterile solution', 'Glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '50%', '1', '', '', '', '', 909, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17489, 'Dextrose 5% & sodium chloride 0.45% (el nasr) i.v. inf. 500 ml (rubber cap)', 'دكستروز 5% و صوديوم كلورايد 0.45% (النصر) محلول وريدي 500 مل بغطاء مطاطي', '5', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'El nasr', 'Cap', 'كبسولة', '5%', '1', '', '', '', '', 1145, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17490, 'Dextrose 5% & sodium chloride 0.45% (otsuka) i.v. inf. 1000 ml (n/a)', 'دكستروز 5% و صوديوم كلوريد 0.45% اوتوسوكا محلول وريدي 1000 مل', '6', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 750, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17491, 'Dextrose 5% & sodium chloride 0.45% (500ml) (rom) i.v.infusion', 'دكستروز 5% صوديوم كلوريد 0.45% 500 مل محلول وريد', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'El nasr', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 814, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17492, 'Dextrose 5% & sodium chloride 0.45% (otsuka) i.v. inf. 500 ml (rubber cap)', 'دكستروز 5% و صوديوم كلورايد 0.45% اوتوسوكا محلول وريدي 500 مل بغطاء مطاطي', '18', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Cap', 'كبسولة', '5%', '1', '', '', '', '', 903, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17493, 'Dextrose 5% & sodium chloride 0.45% (otsuka) i.v. inf. 250 ml', 'دكستروز 5% وصوديوم كلورايد 0.45% اوتوسوكا محلول وريدي 250 مل', '10', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 767, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17494, 'Dextrose 5% & sodium chloride 0.45% (otsuka) i.v. inf. 500 ml', 'دكستروز 5% وصوديوم كلورايد 045% اوتوسوكا محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Otsuka', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 864, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17495, 'Dextrose 5% & sodium chloride 0.9% (allmed) i.v. inf. 500 ml', 'دكستروز 5% و صوديوم كلورايد 0.9% اولميد محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Allmed middle east', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 976, '2022-07-26', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17496, 'Dextrose 5% & sodium chloride 0.9% (allmed) i.v. inf. 500 ml (rubber cap)', 'دكستروز 5% و صوديوم كلورايد 0.9% اولميد محلول وريدي 500 مل بغطاء مطاطي', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'Allmed middle east', 'Cap', 'كبسولة', '5%', '1', '', '', '', '', 926, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17497, 'Aaa', 'ششش', '18', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 912, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17498, 'Dextrose 5% & sodium chloride 0.9% (el nile) i.v. inf. 250 ml', 'دكستروز 5% و صوديوم كلورايد 0.9% النيل محلول وريدي 250 مل', '10', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'El nile.', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 666, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17499, 'Dextrose 5% & sodium chloride 0.9% (el nile) i.v. inf. 500 ml', 'دكستروز 5% و صوديوم كلورايد 0.9% النيل محلول وريدي 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)+sodium chloride', 'El nile.', 'Unknown', 'غير محدد', '5%', '1', '', 'about glucose monosaccharide aldohexose nutritive sweetner. mechanism of action of glucose glucose is a simple carbohydrate and is used as energy source in man. it is readily converted to fat which provides a rich store of energy in concentrated form. glu', '', '', 873, '2022-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17500, 'Dextrose 5% (allmed) i.v. inf. 500 ml (rubber cap)', 'دكستروز 5% اولميد محلول وريدي 500 مل بغطاء مطاطي', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'Allmed middle east', 'Cap', 'كبسولة', '5%', '1', '', '', '', '', 866, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17501, 'Dextrose 5% (el nile) i.v. inf. 500 ml', 'دكستروز 5% النيل محلول وريدي زجاجة 500 مل', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'El nile', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 773, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17502, 'Dextrose 5% (el nile) i.v. inf. 500 ml (rubber cap)', 'دكستروز 5% النيل محلول وريدي 500 مل غطاء مطاطي', '11', '', 'Sterile solution', 'Glucose (dextrose)', 'El nile', 'Cap', 'كبسولة', '5%', '1', '', '', '', '', 695, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17503, 'Dextrose 5% (mottahedoon) i.v. inf. 500 ml', 'دكستروز 5% المتحدون محلول وريدي 500 مل', '13', '', 'Sterile solution', 'Glucose (dextrose)', 'Al mottahedoon pharma', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 797, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17504, 'Dextrose 5% (mup) i.v. inf. 500 ml', 'دكستروز 5% المهن محلول وريدي 500 مل', '33', '17.5', 'Sterile solution', 'Glucose (dextrose)', 'Mup', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 802, '2024-09-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17505, 'Dextrose 5% (vacsera) i.v. inf. 500 ml (n/a)', 'دكستروز 5% فاكسيرا محلول وريدي 500 مل', '8', '', 'Sterile solution', 'Glucose (dextrose)', 'Vacsera', 'Unknown', 'غير محدد', '5%', '1', '', '', '', '', 673, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17506, 'Dextrose 50% (misr) i.v. inj. 20 amp.', 'دكستروز 50% مصر محلول وريدي 20 امبول', '10', '', 'Sterile solution', 'Glucose (dextrose)', 'Misr', 'Inj', 'حقن', '50%', '1', '', '', '', '', 806, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17507, 'Dextrose 50% (otsuka) i.v. inf. 25 ml', 'دكستروز 50% اوتوسوكا محلول وريدي 25 مل', '3', '', 'Sterile solution', 'Glucose (dextrose)', 'Otsuka', 'Unknown', 'غير محدد', '50%', '1', '', '', '', '', 669, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17508, 'Aaa', 'ششش', '13', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 619, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17509, 'Aaa', 'ششش', '11', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 710, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17510, 'Dextrose 25% (misr) i.v. inj. 20 amp.', 'دكستروز 25% مصر محلول وريدي 20 امبول', '8', '', 'Sterile solution', 'Glucose (dextrose)', 'Misr', 'Inj', 'حقن', '25%', '1', '', 'about dextrose dextrorotatory form of monosaccharide(((glucose))) in hypoglycemia and as a sweetner. mechanism of action of dextrose dextrose is used as an intravenous (((iv))) solution used to supply water and calories to the body. it is also used as dil', '', '', 1006, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10B', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17511, 'Dg-care mouth wash 220 ml', 'دي جي كير غسول للفم 220 مل', '65', '', '', 'Chlorhexidine+propolis+calcium carbonate+sodium bicarbonate', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '220 ml', '1', '', '', '6223004160103', '', 799, '2022-09-23', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17512, 'Azotec dex massage cream 50 gm', 'ازوتك دكس مساج كريم 50 جم', '99', '', 'Massage cream', 'Tocopherol (vit e)+laurocapram+menthol+eucalyptus globulus leaf (eucalyptus)+eugenia caryophyllus flower extract (clove)+allantoin+magnesium sulfate+(camphora oil)+panax ginseng root extract+persea gratissima oil (avocado oil)+butyrospermum parkii butter (shea butter)+glyceryl stearate+arctium lappa root extract+carbomer+phenoxyethanol+10-hydroxystearic acid+triethanolamine', 'Koncieve', 'Cream', 'كريم', '50 gm', '1', '', '', '', '', 1136, '2022-09-23', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17513, 'Dg-wash clove mouth wash 125ml', 'دي جي-ووش غسول للفم 125 مل', '35', '19.95', 'Oral care', 'Chlorhexidine+clove oil+propolis', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '125ml', '1', '', '', '6223004160561', '', 1062, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17514, 'Dg-wash clove mouth wash 220ml', 'دي جي-ووش غسول للفم 220 مل', '65', '29.95', 'Oral care', 'Chlorhexidine+clove oil+propolis', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '220ml', '1', '', 'new squeazy bottle', '', '', 1163, '2022-07-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17515, 'Dg-wash fluoride mouth wash 125ml', 'دي جي غسول غسول للفم 125 مل', '35', '', 'Oral care', 'Beepropolis+fluoride+menthol crystals', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '125ml', '1', '', '', '6223004160257', '', 863, '2023-04-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17516, 'Dg-wash fluoride mouth wash 220ml', 'دي جي فلوريد مضمضة 220 مل', '65', '65', 'Oral care', 'Beepropolis+fluoride+menthol crystals', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '220ml', '1', 'منعش للفم والحلق -- مسكن ومطهر ومضاد للالتهاب', 'new squeazy bottle', '6223004160257', '', 1321, '2024-10-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17517, 'Pimoroyal cream 15 gm', 'بيمورويال كريم 15 جم', '173', '', 'Immunomodulator', 'Pimecrolimus', 'Royal link pharma', 'Cream', 'كريم', '15 gm', '1', '', '', '', '', 843, '2024-05-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Pimecrolimus is an immunomodulating agent that was first marketed by Novartis under the trade name Elidel. It is now promoted in Canada by Galderma since early 2007. It is currently available as a topic cream used in the treatment of atopic dermatitis (eczema).', '["D11AH02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17519, 'Dhea 25 mg 100 tablets (illegal import)', 'دي اتش اي ايه 25 مجم 100 قرص', '0', '', '', 'Dhea (dehydroepiandrosterone)', 'Puritans pride', 'Tablet', 'أقراص', '25 mg', '1', '', 'levels of dhea can decline with age as part of the natural aging process. dhea is a hormone that is produced in our bodies by the adrenal glands and the levels of this hormone may begin to decline after the age of 30. supplementing may help replenish what', '', '', 671, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17520, 'Dhea 50 mg 100 tablets (illegal import)', 'دهيا 50مجم 100 قرص', '550', '0', '', 'Dhea (dehydroepiandrosterone)', 'Puritans pride', 'Tablet', 'أقراص', '50 mg', '1', '', 'levels of dhea can decline with age as part of the natural aging process. dhea is a hormone that is produced in our bodies by the adrenal glands and the levels of this hormone may begin to decline after the age of 30. supplementing may help replenish what', '', '', 1512, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17521, 'Diaben 5mg 20 tab.', 'ديابين 5مجم 20 قرص', '4', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glibenclamide(glyburide)', 'Pharco', 'Tab', 'أقراص', '5mg', '2', '', 'about glibenclamide second generation sulfonylurea oral anti-diabetic. mechanism of action of glibenclamide the drug exerts it`s action by increasing insulin release from the pancreas and by improving glucose tolerance. it acts on the sulfonylurea recepto', '6221151002567', '', 1077, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB01', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17522, 'Aaa', 'ششش', '5', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 729, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17523, 'Bomiadex spray 30 ml', 'بوميادكس سبراي لجفن العين 30 مل', '215', '185', 'Eyelid cleanser', 'Melaleuca alternifolia leaf oil', 'Bomian pharmacutical', 'Spray', 'بخاخ', '30 ml', '1', '', '', '', '', 4215, '2025-07-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17525, 'Diabetic support formula 60 caplets (illegal import)', 'دايبتك سبورت فورميولا 60 كبسولة', '0', '', 'Multivitamins', '', 'Puritans pride', 'Cap', 'كبسولة', '', '1', 'فيتامينات متعددة', 'ingredients: vitamin c+vitamin d3+vitamin e+biotin+magnesium+zinc+selenium+manganese+chromium+cinnamon ext.+gymnema+taurine+alpha lipoic acid+leutin these high-potency tablets contain a synergistic blend of chromium picolinate alpha lipoic acid cinnamon g', '', '', 962, '2022-05-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17527, 'Empaglutech 10mg 30 tabs', 'امباجلوتك 10مجم 30 قرص', '231', '', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Empagliflozin', 'Mash premiere', 'Tab', 'أقراص', '10mg', '3', '', '', '', '', 1362, '2024-06-06', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney.[A203453] It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus.[L13688]

The first known inhibitor of SGLTs, phlorizin, was isolated from the bark of apple trees in 1835 and researched extensively into the 20th century, but was ultimately deemed inappropriate for clinical use given its lack of specificity and significant gastrointestinal side effects.[A203501] Attempts at overcoming these limitations first saw the development of O-glucoside analogs of phlorizin (e.g. [remogliflozin etabonate]), but these molecules proved relatively pharmacokinetically unstable. The development of C-glucoside phlorizin analogs remedied the issues observed in the previous generation, and led to the FDA approval of [canagliflozin] in 2013 and both [dapagliflozin] and empagliflozin in 2014.[A203501] As the most recently approved of the "flozin" drugs, empagliflozin carries the highest selectivity for SGLT2 over SGLT1 (approximately 2700-fold). Empagliflozin was further approved by the EMA in March 2022 and Health Canada in April 2022, making it the first and only approved treatment in Europe and Canada for adults with symptomatic chronic heart failure regardless of ejection fraction.[L40783,L13916]', '["A10BD19", "A10BD20", "A10BK03", "A10BD27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17528, 'Diabetin plus 15/850mg 10 f.c.tab.', 'ديابيتين بلس 15/850 مجم 10 اقراص', '9', '', 'Anti-diabetic.sensitizers.combined glitazone +biguanide', 'Metformin+pioglitazone', 'Unipharma co.', 'Tab', 'أقراص', '850mg', '1', '', '', '', '', 781, '2022-07-27', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17529, 'Diabetless 4mg 10 scored tab.', 'ديابتلس 4 مجم 10 اقراص', '6', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Bioriginal international group pharma egypt', 'Tab', 'أقراص', '4mg', '1', '', 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', '', '', 702, '2022-07-21', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present,[A177715] as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake.[A177709] 

Glimepiride works by stimulating the secretion of insulin granules from pancreatic islet beta cells by blocking ATP-sensitive potassium channels (KATPchannels) and causing depolarization of the beta cells. Compared to [glipizide], another second SU drug, glimepiride has a longer duration of action. It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.[A177703] Compared to other SUs, glimepiride was associated with a lower risk of developing hypoglycemia and weight gain in clinical trials [A177709] as well as fewer cardiovascular effects than other SUs due to minimal effects on ischemic preconditioning of cardiac myocytes.[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type 2 diabetes mellitus.[A177703] Glimepiride was approved by the Food and Drug Administration (FDA) in the United States in 1995 for the treatment of T2DM. It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.', '["A10BD04", "A10BB12", "A10BD06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17530, 'Diabeto 2 mg 20 tab.', 'ديابيتو 2 مجم 20 قرص', '16', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Hi-pharm', 'Tab', 'أقراص', '2 mg', '2', '', 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', '', '', 1243, '2022-07-18', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present,[A177715] as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake.[A177709] 

Glimepiride works by stimulating the secretion of insulin granules from pancreatic islet beta cells by blocking ATP-sensitive potassium channels (KATPchannels) and causing depolarization of the beta cells. Compared to [glipizide], another second SU drug, glimepiride has a longer duration of action. It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.[A177703] Compared to other SUs, glimepiride was associated with a lower risk of developing hypoglycemia and weight gain in clinical trials [A177709] as well as fewer cardiovascular effects than other SUs due to minimal effects on ischemic preconditioning of cardiac myocytes.[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type 2 diabetes mellitus.[A177703] Glimepiride was approved by the Food and Drug Administration (FDA) in the United States in 1995 for the treatment of T2DM. It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.', '["A10BD04", "A10BB12", "A10BD06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17532, 'Diabetonorm plus 500/15 mg 15 f.c. tabs', 'ديابيتونورم بلس 500/15مجم 15 قرص', '16', '', 'Anti-diabetic.sensitizers.combined glitazone +biguanide', 'Metformin+pioglitazone', 'October pharma', 'Tab', 'أقراص', '15 mg', '1', '', '', '', '', 812, '2022-06-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17533, 'Diabetonorm plus 850/15 mg 15 f.c. tabs', 'ديابيتونورم بلس 850/15مجم 15 قرص', '17', '', 'Anti-diabetic.sensitizers.combined glitazone +biguanide', 'Metformin+pioglitazone', 'October pharma', 'Tab', 'أقراص', '15 mg', '1', '', '', '', '', 968, '2022-06-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17534, 'Diabetron 40mg 20 tab.', 'ديابترون 40 مجم 20 قرص3', '6', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Gliclazide', 'Amoun', 'Tab', 'أقراص', '40mg', '2', '', 'about gliclazide first generation sulfonylurea oral antidiabetic agent. mechanism of action of gliclazide it is an antidiabetic drug which exerts it`s action by increasing insulin release from the pancreas and by improving glucose tolerance. it acts on th', '6221025003973', '', 814, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB09', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17535, 'Diabetron 80mg 20 tab.', 'ديابترون 80 مجم 20 قرص', '9', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Gliclazide', 'Amoun', 'Tab', 'أقراص', '80mg', '2', '', 'about gliclazide first generation sulfonylurea oral antidiabetic agent. mechanism of action of gliclazide it is an antidiabetic drug which exerts it`s action by increasing insulin release from the pancreas and by improving glucose tolerance. it acts on th', '6221025003980', '', 814, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB09', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17536, 'Diabex 120 mg 10 f.c. tab.', 'ديابكس 120 مجم 10 قرص', '12', '', 'Anti-diabetic.secretagogues.glinides', 'Nateglinide', 'Sedico', 'Tab', 'أقراص', '120 mg', '1', '', 'about nateglinide meglitinide derivative oral antidiabetic agent. mechanism of action of nateglinide it is a quick and short acting antidiabetic drug which exerts it`s action by stimulating insulin release from ?-cells of pancreas. it acts by binding to s', '', '', 790, '2022-07-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Nateglinide is an amino acid derivative that induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naïve to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is dependent on the presence of glucose. In addition to reducing postprandial and fasting blood glucose, meglitnides have been shown to decrease glycosylated hemoglobin (HbA1c) levels, which are reflective of the last 8-10 weeks of glucose control. Meglitinides appear to be more effective at lowering postprandial blood glucose than metformin, sulfonylureas and thiazolidinediones. Nateglinide is extensively metabolized in the liver and excreted in urine (83%) and feces (10%). The major metabolites possess less activity than the parent compound. One minor metabolite, the isoprene, has the same potency as its parent compound.', '["A10BX03"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17537, 'Diabride 1mg 10 tab.', 'ديابرايد 1 مجم 10 قرص', '5', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Sedico', 'Tab', 'أقراص', '1mg', '1', '', 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', '6221042065015', '', 734, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present,[A177715] as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake.[A177709] 

Glimepiride works by stimulating the secretion of insulin granules from pancreatic islet beta cells by blocking ATP-sensitive potassium channels (KATPchannels) and causing depolarization of the beta cells. Compared to [glipizide], another second SU drug, glimepiride has a longer duration of action. It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.[A177703] Compared to other SUs, glimepiride was associated with a lower risk of developing hypoglycemia and weight gain in clinical trials [A177709] as well as fewer cardiovascular effects than other SUs due to minimal effects on ischemic preconditioning of cardiac myocytes.[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type 2 diabetes mellitus.[A177703] Glimepiride was approved by the Food and Drug Administration (FDA) in the United States in 1995 for the treatment of T2DM. It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.', '["A10BD04", "A10BB12", "A10BD06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17538, 'Diabride 2mg 10 tab.', 'ديابرايد 2 مجم 10 قرص', '7', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Sedico', 'Tab', 'أقراص', '2mg', '1', '', 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', '6221042066012', '', 768, '2022-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present,[A177715] as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake.[A177709] 

Glimepiride works by stimulating the secretion of insulin granules from pancreatic islet beta cells by blocking ATP-sensitive potassium channels (KATPchannels) and causing depolarization of the beta cells. Compared to [glipizide], another second SU drug, glimepiride has a longer duration of action. It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.[A177703] Compared to other SUs, glimepiride was associated with a lower risk of developing hypoglycemia and weight gain in clinical trials [A177709] as well as fewer cardiovascular effects than other SUs due to minimal effects on ischemic preconditioning of cardiac myocytes.[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type 2 diabetes mellitus.[A177703] Glimepiride was approved by the Food and Drug Administration (FDA) in the United States in 1995 for the treatment of T2DM. It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.', '["A10BD04", "A10BB12", "A10BD06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17539, 'Aaa', 'ششش', '8', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 789, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17540, 'Diabride 6 mg 10 tab.', 'ديابريد 6مجم 10 قرص', '8', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Glimepiride', 'Sedico', 'Tab', 'أقراص', '6 mg', '1', '', 'indications : this medication is a sulfonylurea antidiabetic agent prescribed for type 2 diabetes. it works by causing the pancreas to produce insulin dosage : the recommended starting dose is 1-2 mg once daily with food.maximum: 2mg/day contraindications', '', '', 787, '2022-07-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present,[A177715] as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake.[A177709] 

Glimepiride works by stimulating the secretion of insulin granules from pancreatic islet beta cells by blocking ATP-sensitive potassium channels (KATPchannels) and causing depolarization of the beta cells. Compared to [glipizide], another second SU drug, glimepiride has a longer duration of action. It is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs.[A177703] Compared to other SUs, glimepiride was associated with a lower risk of developing hypoglycemia and weight gain in clinical trials [A177709] as well as fewer cardiovascular effects than other SUs due to minimal effects on ischemic preconditioning of cardiac myocytes.[A177703] It is effective in reducing fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels and is considered to be a useful, cost-effective treatment option for managing type 2 diabetes mellitus.[A177703] Glimepiride was approved by the Food and Drug Administration (FDA) in the United States in 1995 for the treatment of T2DM. It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.', '["A10BD04", "A10BB12", "A10BD06"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17541, 'Coxorizet 60 mg 20 tabs', 'كوكسوريزيت 60 مجم 20 قرص', '158', '107', 'Nsaid.selective cox-2 inhibitors', 'Etoricoxib', 'Zeta pharma', 'Tab', 'أقراص', '60 mg', '2', '', '', '6225000561557', '', 1377, '2025-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AH05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17542, 'Diacalderm topical oint. 20 gm', 'دياكالديرم مرهم 20 جرام', '88', '60', 'Psoriasis', 'Betamethasone+calcipotriol(calcipotriene)', 'Marcyrl co.', 'Oint', 'مرهم', '20 gm', '1', 'يعمل على الحد من التورم، والاحمرار، والحكة التي تصاحب عدوى الجلد، ويساعد على مقاومة الألم والالتهاب.', 'uses: this medication is used to treat psoriasis. it helps to reduce the redness thickening and scaling of the skin that occurs with this condition. healthy skin lowers your risk for infection and protects you against the environment. this product contain', '6223003575809', '', 4775, '2025-03-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17543, 'Aaa', 'ششش', '177', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 760, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17544, 'Diacanram 100 mg 10 f.c. tabs.', 'دياكانرام 100 مجم 10 أقراص', '87', '', 'Anti-diabetic', 'Canagliflozin', 'Rameda', 'Tab', 'أقراص', '100 mg', '1', 'علاج مرض السكري', 'canagliflozin is an oral diabetes medicine that helps control blood sugar levels. canagliflozin works by helping the kidneys get rid of glucose from your bloodstream. canagliflozin is used together with diet and exercise to treat type 2 diabetes. canaglif', '', '', 1029, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Canagliflozin, also known as _Invokana_, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus along with lifestyle changes including diet and exercise [FDA label].

It was initially approved by the FDA in 2013 for the management of diabetes and later approved in 2018 for a second indication of reducing the risk of cardiovascular events in patients diagnosed with type 2 diabetes mellitus [L5897], [FDA label]. 

Canagliflozin is the first oral antidiabetic drug approved for the prevention of cardiovascular events in patients with type 2 diabetes [L5897]. Cardiovascular disease is the most common cause of death in these patients [A177083].', '["A10BD16", "A10BK02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17545, 'Diacanram 300 mg 10 f.c. tabs.', 'دياكانرام 300 مجم 10 اقراص', '0', '', 'Anti-diabetic', 'Canagliflozin', 'Rameda', 'Tab', 'أقراص', '300 mg', '1', '', 'canagliflozin is an oral diabetes medicine that helps control blood sugar levels. canagliflozin works by helping the kidneys get rid of glucose from your bloodstream. canagliflozin is used together with diet and exercise to treat type 2 diabetes. canaglif', '', '', 819, '2022-07-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Canagliflozin, also known as _Invokana_, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus along with lifestyle changes including diet and exercise [FDA label].

It was initially approved by the FDA in 2013 for the management of diabetes and later approved in 2018 for a second indication of reducing the risk of cardiovascular events in patients diagnosed with type 2 diabetes mellitus [L5897], [FDA label]. 

Canagliflozin is the first oral antidiabetic drug approved for the prevention of cardiovascular events in patients with type 2 diabetes [L5897]. Cardiovascular disease is the most common cause of death in these patients [A177083].', '["A10BD16", "A10BK02"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17546, 'Nano repair 25 gm gel', 'نانو ريبير جل 25 جم', '89', '', 'Acute chronic wound.burn healing', 'Silver nano particles+calendula officinalis extract+poly vinyl pyyrildone+glycerin+poly ethylene glycol+carbomer', 'Modern nano', 'Gel', 'جل', '25 gm', '1', '', '', '', '', 1001, '2024-07-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17548, 'Diacurimap 10 mg 30 f.c. tabs.', 'دياكيوريماب 10مجم 30 قرص', '204', '150', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Empagliflozin', 'Multi-apex', 'Tab', 'أقراص', '10 mg', '3', 'لمرضى السكر', 'it is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes alone or along with other antidiabetic medicines and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who hav', '6223003206352', '', 13222, '2024-03-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney.[A203453] It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus.[L13688]

The first known inhibitor of SGLTs, phlorizin, was isolated from the bark of apple trees in 1835 and researched extensively into the 20th century, but was ultimately deemed inappropriate for clinical use given its lack of specificity and significant gastrointestinal side effects.[A203501] Attempts at overcoming these limitations first saw the development of O-glucoside analogs of phlorizin (e.g. [remogliflozin etabonate]), but these molecules proved relatively pharmacokinetically unstable. The development of C-glucoside phlorizin analogs remedied the issues observed in the previous generation, and led to the FDA approval of [canagliflozin] in 2013 and both [dapagliflozin] and empagliflozin in 2014.[A203501] As the most recently approved of the "flozin" drugs, empagliflozin carries the highest selectivity for SGLT2 over SGLT1 (approximately 2700-fold). Empagliflozin was further approved by the EMA in March 2022 and Health Canada in April 2022, making it the first and only approved treatment in Europe and Canada for adults with symptomatic chronic heart failure regardless of ejection fraction.[L40783,L13916]', '["A10BD19", "A10BD20", "A10BK03", "A10BD27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17549, 'Diacurimap 25 mg 30 f.c. tabs.', 'دياكيوريماب 25مجم 30 قرص', '204', '150', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Empagliflozin', 'Multi-apex', 'Tab', 'أقراص', '25 mg', '3', 'لمرضى السكر', 'it is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes alone or along with other antidiabetic medicines and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who hav', '6223003206444', '', 14971, '2024-01-23', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney.[A203453] It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus.[L13688]

The first known inhibitor of SGLTs, phlorizin, was isolated from the bark of apple trees in 1835 and researched extensively into the 20th century, but was ultimately deemed inappropriate for clinical use given its lack of specificity and significant gastrointestinal side effects.[A203501] Attempts at overcoming these limitations first saw the development of O-glucoside analogs of phlorizin (e.g. [remogliflozin etabonate]), but these molecules proved relatively pharmacokinetically unstable. The development of C-glucoside phlorizin analogs remedied the issues observed in the previous generation, and led to the FDA approval of [canagliflozin] in 2013 and both [dapagliflozin] and empagliflozin in 2014.[A203501] As the most recently approved of the "flozin" drugs, empagliflozin carries the highest selectivity for SGLT2 over SGLT1 (approximately 2700-fold). Empagliflozin was further approved by the EMA in March 2022 and Health Canada in April 2022, making it the first and only approved treatment in Europe and Canada for adults with symptomatic chronic heart failure regardless of ejection fraction.[L40783,L13916]', '["A10BD19", "A10BD20", "A10BK03", "A10BD27"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17550, 'Diadel cream 20 gm', 'دياديل كريم 20جم', '45', '', '', 'Camphor+menthol+l-arginine+glycerin', 'Leader for cosmetics >', 'Cream', 'كريم', '20 gm', '1', 'ستخدم لعلاج والتخفيف من أعراض البواسير.الحد من التهاب منطقة الشرج.', '', '6280201379622', '', 1266, '2022-08-03', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17551, 'Diaflozimet 10/1000 mg 30 ext. rel . f.c. tabs.', 'ديافلوزيميت 10/1000مجم 30 قرص ممتد المفعول', '258', '231.75', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Eva pharma', 'Tab', 'أقراص', '1000 mg', '3', 'لعلاج ارتفاع السكر بالدم', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224009967049', '', 14318, '2023-09-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17552, 'Diaflozimet 10/500 mg 30 ext. rel . f.c. tabs.', 'ديافلوزيميت 10/500مجم 30 قرص ممتد المفعول', '258', '231.75', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Eva pharma', 'Tab', 'أقراص', '500 mg', '3', 'لعلاج مرضى ارتفاع سكر الدم', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224009967032', '', 1425, '2023-09-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17553, 'Diaflozimet 5/1000 mg 30 ext. rel . f.c. tabs.', 'ديافلوزيميت 5/1000مجم 30 قرص ممتد المفعول', '191', '162', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Eva pharma', 'Tab', 'أقراص', '1000 mg', '3', 'لعلاج مرضى ارتفاع السكر بالدم', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224009967025', '', 4310, '2023-09-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17554, 'Diaflozimet 5/500 mg 30 ext. rel . f.c. tabs.', 'ديافلوزيميت 5/500مجم 30 قرص ممتد المفعول', '191', '162', 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Dapagliflozin+metformin', 'Eva pharma', 'Tab', 'أقراص', '500 mg', '3', 'لعلاج مرضى ارتفاع السكر بالدم', 'mechanism of action dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (sglt2) which are responsible for at least 90% of the glucose reabsorption in the kidney. blocking this transporter mechanism causes blood glucose to be eliminat', '6224007326794', 'http://www.evapharma.com/portfolio/Diaflozimet/', 1900, '2024-12-04', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17555, 'Dia-furyl 100mg 20 caps.', 'ديا-فيورل 100مجم 20 كبسولة', '9', '9', 'Antidiarrheal', 'Nifuroxazide', 'Borg', 'Cap', 'كبسولة', '100mg', '2', '', 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', '6223002570232', '', 988, '2024-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A07AX03', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17556, 'Dia-furyl 200mg 10 caps.', 'ديا-فيوريل 200 مجم 10 كبسولات', '17', '8.5', 'Antidiarrheal', 'Nifuroxazide', 'Borg', 'Cap', 'كبسولة', '200mg', '1', '', 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', '6223002570607', '', 948, '2024-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A07AX03', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17557, 'Aaa', 'ششش', '9', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 734, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17558, 'Like 50 gm moisturizing cream', 'لايك كريم مرطب 50 جم', '75', '', 'Moisturizing cream', 'Panthenol - alovera extract - cucumber extract - petrolatum - honey - chamomile ext - soybean oil - vit e - vit c - allantoin - beeswax - glycerin', 'Therapy pharm', 'Cream', 'كريم', '50 gm', '1', '', '', '', '', 759, '2024-08-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17559, 'Diaguard 30 caps.', 'دياجارد 30 كبسولة', '26', '', 'Dietary supplement', 'Chromium+vandyl+magnesium+floc acid+vitamin b6+vitamin b12', 'Safe pharma > epci', 'Cap', 'كبسولة', '', '3', '', '*composition: each capsule contains: chromium picolinate 1mg + vanadyl sulphate 100mg + magnesium oxide 350mg + folic acid 0.8mg + vitamin b6 25mg + vitamin b12 0.5mg * indications: multivitamins formula used especially for diabetic patients against diabe', '', '', 752, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17560, 'Hoffcarbon 20 capsule', 'هوفكاربون 20 كبسولة', '88', '', 'Anti flatulent', 'Activated charcoal 290 mg+anise extract 100 mg+peppermint extract 80 mg', 'Hoffmann pharm', 'Capsule', 'كبسولة', '', '2', '', '', '', '', 787, '2024-09-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17561, 'Scomeb lotion spray', 'سكوميب لوشن سبراي', '120', '95', '', '', 'Company', 'Lotion', 'لوشن', '', '1', '', '', '', '', 1054, '2025-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17562, 'Ginkonoro 30 tablet', 'جينكونورو 30 قرص', '170', '150', 'Multivitamins', 'Ginkgo biloba+choline chloride+lecithin+vitamin b12+b6+b2+b1+folic acid+vitamin d3', 'Egy minds', 'Tablet', 'أقراص', '', '3', '', '', '', '', 915, '2025-08-20', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17563, 'Dopa plus syrup 75 ml', 'دوبا بلس شراب 75 مل', '210', '', '', 'Dopamine', 'Company', 'Syrup', 'شراب', '75 ml', '1', '', '', '', '', 1620, '2024-09-14', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'One of the catecholamine neurotransmitters in the brain.  It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action.', '["C01CA04"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17564, 'Diamicron mr 60 mg 30 scored tab.', 'دياميكرون 60مجم 30 قرص', '156', '108', 'Anti-diabetic.secretagogues.sulfonylurea', 'Gliclazide', 'Servier', 'Tab', 'أقراص', '60 mg', '3', 'علاج مرض ارتفاع السكر بالدم', '', '6223003960704', '010622300396070411250120172801201034938', 21697, '2025-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB09', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17565, 'Norvasc 5mg 10 tab.', 'نورفاسك 5مجم 10 قرص', '54', '', 'Antihypertensive.selective calcium channel blocker', 'Amlodipine', 'Pfizer', 'Tab', 'أقراص', '5mg', '1', '', '', '', '', 1062, '2022-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Amlodipine, initially approved by the FDA in 1987, is a popular antihypertensive drug belonging to the group of drugs called _dihydropyridine calcium channel blockers_.  Due to their selectivity for the peripheral blood vessels, dihydropyridine calcium channel blockers are associated with a lower incidence of myocardial depression and cardiac conduction abnormalities than other calcium channel blockers [A175327].

Amlodipine is commonly used in the treatment of high blood pressure and angina. Amlodipine has antioxidant properties and an ability to enhance the production of nitric oxide (NO), an important vasodilator that decreases blood pressure [A175321].  The option for single daily dosing of amlodipine is an attractive feature of this drug [FDA label].', '["C09XA54", "C10BX07", "C09BB03", "C09BB04", "C07FB07", "C09DB06", "C10BX18", "C07FB12", "C09DB05", "C09XA53", "C10BX03", "C07FB13", "C08CA01", "C09BX04", "C09BX03", "C09DB04", "C09DX03", "C08GA02", "C09DB07", "C09DX06", "C09BX01", "C10BX11", "C09DB02", "C10BX09", "C08CA51", "C09DX01", "C09DB09", "C09DB01", "C10BX14", "C09BB07", "C09DX07"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17566, 'Diamicron 80mg 20 scored tab', 'دياميكرون80 مجم 20 قرص', '17', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Gliclazide', 'Servier', 'Tab', 'أقراص', '80mg', '2', '', '', '6223003960087', '', 971, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB09', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17567, 'Pharmavildamin 50/850mg 30 tab', 'فارمافيلدامين 50/1000مجم 30 قرص', '159', '121.5', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Vildagliptin+metformin', 'Pharma care', 'Tab', 'أقراص', '850mg', '3', '', '', '6224009003501', '', 1123, '2025-07-30', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17568, 'Diamond hair lotion 200 ml', 'دياموند لوشن للشعر 200 مل', '52', '', 'Hair care', 'Jojoba oil+olive leaves+tea tree oil+rosemary+sage leaves+eruca leaves+panthenol+chamomile+salicylic', 'El-helou perfumes & cosmetics > pharmavera pharmaceutical co.', 'Lotion', 'لوشن', '200 ml', '1', '', '', '', '', 788, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17569, 'Diamond teething gel 50 gm', 'دياموند جل للاسنان 50 جم', '12', '', 'Oral care', 'Menthol+chlorhexidine+thyme+sorbitol+eucalyptus+sodium bicarbonate+calcium carbonate+sodium fluoride', 'El-helou perfumes & cosmetics > pharmavera pharmaceutical co.', 'Gel', 'جل', '50 gm', '1', 'جل لتخفيف الالم الاسنان', 'for prevention and treatment of fungal and bacterial infection in mouth.', '', '', 921, '2022-05-31', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17570, 'Diamonrecta 20 mg 2 f.c.tabs.', 'ديامونريكتا 20مجم 2 قرص', '70', '50', 'Tonic for men', 'Tadalafil', 'Eva pharma', 'Tab', 'أقراص', '20 mg', '2', 'مقوي للرجال', '', '6223004512698', '', 1970, '2023-10-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17573, 'Diamonrecta 20 mg 5 oro-dispersible films', 'ديامونريكتا 20مجم 5 افلام ذائبة بالفم', '125', '', 'Tonic for men', 'Tadalafil', 'Eva pharma', 'Film', 'فيلم', '20 mg', '5', 'مقوي للرجال', '', '6223007350723', '', 2010, '2023-07-15', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17574, 'Diamonrecta 5 mg 30 f.c. tab.', 'ديامونريكتا 5مجم 30 قرص', '188', '', 'Tonic for men', 'Tadalafil', 'Eva pharma', 'Tab', 'أقراص', '5 mg', '3', 'مقوي للرجال', '', '6223004517013', '', 9339, '2023-02-05', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17575, 'Diane 35 - 21 tablets (illegal import)', 'ديان 35 - 21 قرص - مستورد', '0', '', '', 'Ethinyl estradiol+cyproterone', 'Bayer healthcare >', 'Tablet', 'أقراص', '', '1', 'مانع للحمل ويستخدم فى علاج تكيسات المبياض', '', '8699546123179', '010628507400042021659904531599 1725063010KT0F741', 4752, '2023-06-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17576, 'Dianormal 80mg 20 tab.', 'ديانورمال 80 مجم 20 قرص', '9', '', 'Anti-diabetic.secretagogues.sulfonylurea', 'Gliclazide', 'Rameda', 'Tab', 'أقراص', '80mg', '2', '', 'about gliclazide first generation sulfonylurea oral antidiabetic agent. mechanism of action of gliclazide it is an antidiabetic drug which exerts it`s action by increasing insulin release from the pancreas and by improving glucose tolerance. it acts on th', '6223003970079', '', 1029, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BB09', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17578, 'Aaa', 'ششش', '4', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 766, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17579, 'Aaa', 'ششش', '8', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 724, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17580, 'Aaa', 'ششش', '8', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 800, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17581, 'Diarent hair serum 200 ml', 'ديارنت هير سيروم للشعر 200 مل', '240', '180', 'Hair care', 'Argan oil+emu oil+aloe ext+keratin+lavender oil+vit. b6+ginseng ext+garlic oil+castor oil+panthenol', 'Egyptian co. for cosmetics > biocare', 'Serum', 'سيروم', '200 ml', '1', 'للعناية بالشعر', '', '', '', 1851, '2025-08-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17582, 'Diaro whitening cream 30 ml', 'ديارو كريم 30 مل', '119', '', 'Whitening topical', '', 'Egyptian company for cosmetics > oshba', 'Cream', 'كريم', '30 ml', '1', '', '*for best results it should be used for at least 2 months. *avoid direct exposure to the sun.', '', '', 902, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17583, 'Aaa', 'ششش', '13', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 772, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17585, 'Aaa', 'ششش', '24', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 675, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17586, 'Aaa', 'ششش', '10', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 804, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17587, 'Aaa', 'ششش', '7', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 612, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17588, 'Diasmect 3gm 10 sachets', 'دياسميكت 3 جم 10 أكياس', '21', '15', 'Antidiarrheal', 'Dioctahedral smectite', 'Pharopharma', 'Sachet', 'أكياس', '3gm', '10', '', 'dioctahedral smectite mode of action dioctahedral has adsorbent properties and is used in the management of diarrhoea. dioctahedral has unique properties that allow for the adsorption of different toxins (such as rotavirus e. coli and staphylococcus). dio', '6221094010155', '', 2107, '2024-08-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17589, 'Diastat baby lotion 100 ml', 'دياستات محلول 100 مل', '30', '', 'Soothing topical', 'Zinc oxide+chamomile extract+allantoin+dimethicone+glycerol', 'Cosmopack > dr pharma', 'Lotion', 'لوشن', '100 ml', '1', '', 'skin soothing lotion', '', '', 865, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17590, 'Aaa', 'ششش', '15', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 664, '2022-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17591, 'Aaa', 'ششش', '16', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 754, '2022-10-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17592, 'Diavance 2.5/500mg 30 f.c.tab.', 'ديافانس 2.5/500 مجم 30 قرص', '39', '20.25', 'Anti-diabetic.combined secretagogues+sensitizers', 'Glibenclamide(glyburide)+metformin', 'Sigma', 'Tab', 'أقراص', '500mg', '3', '', 'about metformin biguanide derivative oral anti-diabetic. mechanism of action of metformin it is a biguanide which exerts antidiabetic action. the drug suppresses gluconeogenesis in liver and thus suppresses hepatic glucose output. it enhance insulin media', '6221051011348', '', 1257, '2025-08-11', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17594, 'Diax 200mg 12 caps.', 'دياكس 200مجم 12 كبسولة', '21', '13.5', 'Antidiarrheal', 'Nifuroxazide', 'Hikma pharma', 'Cap', 'كبسولة', '200mg', '1', '', 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', '', '', 2396, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A07AX03', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17595, 'Aaa', 'ششش', '11', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 710, '2022-10-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17596, 'Diazocerine 50mg 20 cap', 'ديازوسيرين 50مجم 20 كبسولة', '46', '32.4', 'Antirheumatic.osteoarthritis.anabolic agents', 'Diacerin', 'Egyphar', 'Cap', 'كبسولة', '50mg', '2', 'يستخدم لعلاج الالتهابات المفصلية العظمية ومضاد للالتهاب، وله خواص بنائية للغضاريف والغشاء المفصلي.', '', '', '', 3527, '2025-11-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17598, 'Dibavally 50 mg 14 tabs.', 'ديبافالي 50مجم 14 قرص', '42', '', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Vildagliptin', 'Aug pharma', 'Tab', 'أقراص', '50 mg', '2', '', '', '6223003270148', '', 1122, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BH02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17599, 'Dibavally 50 mg 28 tabs.', 'ديبافالي 50 مجم 28 قرص', '152', '116', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Vildagliptin', 'Aug pharma', 'Tab', 'أقراص', '50 mg', '4', '', '', '6223005460615', '', 961, '2024-09-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A10BH02', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17600, 'Dibavally plus 50/1000 mg 14 tabs.', 'ديبافالي بلس 50/1000مجم 14 قرص', '52', '', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Metformin hydrochloride+vildagliptin', 'Aug pharma', 'Tab', 'أقراص', '1000 mg', '2', 'لمرضى السكر', '', '4936543729398', '', 4081, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17601, 'Dibavally plus 50/1000mg 28 tabs.', 'ديبافالي بلس 50/1000مجم 28 قرص', '184', '140', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Metformin hydrochloride+vildagliptin', 'Aug pharma', 'Tab', 'أقراص', '1000mg', '4', '', '', '6223005460936', '', 3153, '2024-09-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17602, 'Dibiotimycin aerosol powder 150 ml', 'ديبيوتيميسين بودرة 150 مل', '30', '', 'Antibiotic topical', 'Bacitracin+neomycin', 'Egyptian co. for adv. pharma. (ecap)', 'Sol', 'محلول', '150 ml', '1', '', '', '6224000588007', '', 969, '2022-07-09', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, 'D06AX05', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17603, 'Dibiotimycin extra aerosol powder 85 ml', 'ديبيوتيميسين بودرة 85 مل', '28', '', 'Antibiotic topical', 'Bacitracin+neomycin+polymyxin', 'Egyptian co. for adv. pharma. (ecap)', 'Sol', 'محلول', '85 ml', '1', '', '', '', '', 791, '2022-07-25', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17604, 'Dibrex 30 sugar c. tabs.', 'ديبريكس 30 قرص', '17', '', 'Spastic colon', 'Chlordiazepoxide+clidinium bromide', 'Future pharmaceutical industries (fpi) > international trading office', 'Tab', 'أقراص', '', '3', '', '(chlordiazepoxide and clidinium) combines in a single capsule formulation the antianxiety action of chlordiazepoxide hydrochloride and the anticholinergic/spasmolytic effects of clidinium bromide. chlordiazepoxide hydrochloride is a versatile therapeutic', '', '', 1607, '2022-07-08', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17605, 'Diceta cream 30 gm', 'ديسيتا كريم 30 جم', '44', '44', 'Healing topical', 'Chamomile extract+panthenol+sesame oil+peanut oil+cetrimide', 'Hi-care > diamond pharma', 'Cream', 'كريم', '30 gm', '1', '', 'used for treating wounds all types of burns and ulcers.', '6224007258057', '', 1287, '2023-09-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17606, 'Dicetel 100mg 20 f.c. tabs.', 'دايسيتيل 100مجم 20 قرص', '82', '55', 'Smooth muscle relaxant', 'Pinaverium bromide', 'Abbott laboratories', 'Tab', 'أقراص', '100mg', '1', '1- حالات القولون العصبي.', 'about pinaverium bromide a calcium channel blocker for functional gastrointestinal disorder. mechanism of action of pinaverium bromide pinaverium is a calcium channel blocker. it inhibits the calcium influx through voltage-dependent calcium channel in the', '8002660030139', '', 8541, '2024-12-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A03AX04', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17607, 'Diclac 75 mg/3ml 6 amps.', 'ديكلاك 75مجم/3 مل 6 امبولات', '66', '27', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Mina pharm > hexal ag germany', 'Amp', 'أمبول', '75 mg', '6', 'مسكن وخافض للحرارة ومضاد للالتهابات', '', '6223002642588', '', 1334, '2023-10-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17608, 'Aaa', 'ششش', '31', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 654, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17609, 'Diclac 4% gel 50 gm', 'ديكلاك 4% جل 50 جم', '72', '55', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Mina pharm > hexal ag germany', 'Gel', 'جل', '4%', '1', '', '', '', '', 1206, '2024-05-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17610, 'Diclac 75 id 30 prolonged tabs.', 'ديكلاك 75مجم 30 قرص', '135', '', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Sandoz', 'Tab', 'أقراص', '', '3', '', '', '', '', 1399, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17611, 'Aaa', 'ششش', '16', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 763, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17612, 'Aaa', 'ششش', '32', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 663, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17613, 'Dicloferaz 75mg/3ml 6 amp. i.m i.v inf.', 'ديكلوفيراز 75 مجم / 3 مل 6 امبول وريد', '66', '13.5', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Jedco int. co. for pharmaceuticals > elrazy pharmaceuticals-egypt', 'Amp', 'أمبول', '75mg', '6', '', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '', '', 1064, '2024-12-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17614, 'Dicloflam 50mg 10 sugar coated tab.', 'ديكلوفلام 50 مجم 10 اقراص مغطاه بالسكر', '15', '8', 'Nsaid.acetic acid derivatives', 'Diclofenac potassium', 'Alexandria', 'Tab', 'أقراص', '50mg', '1', 'مسكن عام للجسم -- تقليل الالام والالتهابات', 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '', '', 7017, '2024-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17615, 'Diclonatrium sr 75mg 20 f.c. tabs.', 'ديكلونتريوم اس ار 75 مجم 20 قرص', '58', '38', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Organopharma', 'Tab', 'أقراص', '75mg', '2', 'مسكن ومضاد للالتهابات وخافض للحرارة', 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6224000908362', '', 3990, '2025-01-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17616, 'Diclonerve 30 caps.', 'ديكلونيرف 30 كبسولة', '21', '', 'Nsaid combined with vitamin b', 'Diclofenac sodium+vitamin b1+vitamin b6+vitamin b12', 'Adwia', 'Cap', 'كبسولة', '', '3', '', 'mechanism of action of diclofenac sodium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of prostaglandins (pgs). it is more potent against cyclo-oxygenase-2', '6223002977307', '', 1815, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17617, 'Diclopro plus 500/50mg 20 f.c. tabs.', 'ديكلوبرو بلس 500/50 مجم 20 قرص', '43', '', 'Cns.analgesic.skeletal muscle relaxant', 'Diclofenac potassium+methocarbamol', 'Sabaa > pharmakon pharmaceuticals', 'Tab', 'أقراص', '50mg', '2', 'مسكن ومضاد للالتهابات وخافض للحرارة وباسط للعضلات', 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '', '', 4151, '2023-05-19', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17618, 'Aaa', 'ششش', '26', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 799, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17619, 'Diclorelax 20 caps.', 'ديكلوريلاكس 20 كبسولة', '13', '', 'Muscle relaxant', 'Chlorzoxazone+ketoprofen', 'Unipharma co. > al hadidi pharma', 'Cap', 'كبسولة', '', '2', '', '(indications) : this medication is a muscle relaxant prescribed for muscle spasm and the resulting pain or discomfort. it is used in combination with physical therapy analgesics (such as aspirin or acetaminophen) and rest. about chlorzoxazone a benzoxazol', '', '', 1103, '2022-07-24', 0, NULL, NULL, NULL, NULL, 1, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17621, 'Diclotazen 50 mg 10 sachets', 'ديكلوتازين 50 مجم 10 أكياس', '25', '18', 'Nsaid.acetic acid derivatives', 'Diclofenac potassium', 'Medizen pharmaceutical industries', 'Sachet', 'أكياس', '50 mg', '1', '', 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '6222012400003', '', 1358, '2024-01-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17622, 'Diclotazen 50 mg 100 sachets', 'ديكلوتازين 50 مجم 100 كيس', '180', '', 'Nsaid.acetic acid derivatives', 'Diclofenac potassium', 'Medizen pharmaceutical industries', 'Sachet', 'أكياس', '50 mg', '100', '', 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '', '', 795, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17623, 'Diclowad 50mg 12 sachets.', 'ديكلواد 50مجم 12 اكياس', '22', '', 'Nsaid.acetic acid derivatives', 'Diclofenac potassium', 'Egpi > al rowad pharmaceutical industrial co.', 'Sachet', 'أكياس', '50mg', '1', '', 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '', '', 891, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17624, 'Aaa', 'ششش', '24', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 689, '2022-11-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17625, 'Aaa', 'ششش', '18', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 796, '2022-11-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17626, 'Aaa', 'ششش', '42', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 632, '2022-11-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17627, 'Di-ease syrup 120ml', 'داي ايز شراب 120 مل', '8', '', 'Digestive enzymes', 'Belladonna tincture+ginger tincture+papain', 'Pharopharma', 'Syrup', 'شراب', '120ml', '1', '', '', '6221094011190', '', 1212, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17628, 'Diet booster 20 tabs', 'دايت بوستر 20 قرص', '53', '', '', '', 'Egpi', 'Tab', 'أقراص', '', '1', '', '', '9611001101712', '', 832, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17631, 'Diet-sweet 350 tabs', 'دايت-سويت 350 قرص', '74', '60', 'Sweetener', 'Aspartame', 'Amriya', 'Tab', 'أقراص', '', '1', 'سكر دايت -- محلي للطعام -- يستخدم في عدم زيادة الوزن', '', '6221075010112', '', 3080, '2024-03-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17633, 'Diety 300 tabs', 'دايتي 300 قرص', '15', '', 'Sweetener', 'Aspartame', 'Eva pharma', 'Tab', 'أقراص', '', '1', '', '', '6223002450022', '', 716, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17634, 'Diety 50 tabs', 'دايتي 50 قرص', '4', '', 'Sweetener', 'Aspartame', 'Eva pharma', 'Tab', 'أقراص', '', '1', '', '', '6223002454303', '', 837, '2022-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17636, 'Diflorutacine 500mg 30 f.c. tabs.', 'ديفلوروتاسين 500 مجم 30 قرص', '47', '', 'Vascular-protecting agent', 'Diosmin', 'Arab drug company.', 'Tab', 'أقراص', '500mg', '3', '', '', '', '', 1734, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'C05CA03', NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17638, 'Aaa', 'ششش', '98', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 765, '2022-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17639, 'Aaa', 'ششش', '60', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 610, '2022-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17640, 'Aaa', 'ششش', '95', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 675, '2022-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17641, 'Aaa', 'ششش', '95', '', '', '', '', 'Unknown', 'غير محدد', '', '1', '', '', '', '', 717, '2022-09-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17642, 'Diflunazole 25mg/5ml syrup 70ml', 'ديفلونازول 25 مجم / 5 مل شراب 70 مل', '29', '', 'Antifungals.triazoles', 'Fluconazole', 'Cid', 'Syrup', 'شراب', '25mg', '1', '', 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', '', '', 889, '2022-07-12', 0, NULL, NULL, NULL, NULL, 1, 0, 0, 'Fluconazole, commonly known as _Diflucan_, is an antifungal drug used for the treatment of both systemic and superficial fungal infections in a variety of tissues.  It was initially approved by the FDA in 1990. This drug is an _azole_ antifungal, in the same drug family as [ketoconazole] and [itraconazole]. Fluconazole has many advantages over the other antifungal drugs including the option of oral administration. The side effect profile of this drug is minimal. It has been demonstrated as an efficacious treatment for vaginal yeast infections in one single dose.[A174325]', '["J01RA07", "J02AC01", "D01AC15"]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17643, 'Diflustero 0.05% eye emulsion 5 ml', 'ديفلوستيرو 0.05% نقط للعين 5 مل', '45', '45', 'Glucocorticoid', 'Difluprednate', 'Orchidia pharmaceutical industries', 'Unknown', 'غير محدد', '0.05%', '1', '', 'difluprednate is a corticosteroid it is chemically a butyrate ester of 6(alpha) 9(alpha)-difluoro prednisolone acetate. accordingly difluprednate is sometimes abbreviated dfba for difluoroprednisolone butyrate acetate. difluprednate emulsion is used for:', '6224000219802', '', 1323, '2024-09-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'None', '[]', '[]');
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17644, 'Aaa', 'ششش', '38', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 645, '2022-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17645, 'Aaa', 'ششش', '26', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 672, '2022-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17646, 'Digestozyme 20 e.c. tabs.', 'دايجستوزيم 20 قرص', '75', '62', 'Digestive enzymes', 'Pancreatin+papain', 'Pharopharma', 'Tab', 'أقراص', '', '2', 'مهضم وفاتح شهية - انزيمات هاضمة', '', '6221094502735', '', 17429, '2025-10-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR REPLACE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (17648, 'Aaa', 'ششش', '34', '', '', '', '', 'Unknown', 'غير محدد', '', '0', '', '', '', '', 668, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);